List view / Grid view

Megha Baruah (Freyr)



China and the evolving regulatory landscape

4 September 2019 | By

The Chinese pharmaceutical industry has been lagging behind in terms of drug development and bringing new products to the market. In this article, Megha Baruah discusses the changes the National Medical Products Administration (NMPA) of China is making to existing policies and informs on guidance documents that have been released…